Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan

Journal of Clinical Pathology

Volumn 64, Issue 7, 2011, Pages 571-577

  Huang, Cheng Chih ^a   Hsiao, Jenn Ren ^a   Yang, Ming Wei ^a   Wu, Yuan Hua ^a   Hsu, Keng Fu ^a   Chang, Yao ^b   Chen, Chaio Wei ^b   Tsai, Sen Tien ^a   Wei, Hsuan Pei ^a   Jin, Ying Tai ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c Taiwan Adventis Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; MALE; NASOPHARYNX; NASOPHARYNX CARCINOMA; NEOPLASM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STAINING; TAIWAN; VIRUS DETECTION; VIRUS GENOME; WART VIRUS;

EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TAIWAN;

EID: 79959333941     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.087742     Document Type: Article

References (43)

1. Chen CJ, Liang KY, Chang YS, et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malaria infection, cigarette smoking and family tendency. Anticancer Res 1990;10:547-54.
2. Hildeshiem A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993;15:466-85. (Pubitemid 24072639)
3. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005;365:2041-54. (Pubitemid 40812341)
4. Tsai ST, Jin YT, Mann RB, et al. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer 1998;82:1449-53. (Pubitemid 28164988)
5. Niedobitek G, Hansmann ML, Herbst H, et al. EBV and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991;165:17-24.
6. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009;384:260-5.
7. Howley PM. Papillomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott-Raven, 1996:2045-76.
8. Turazza E, Lapena A, Sprovieri O, et al. Low-risk human papillomavirus type 6 and 11 associated with carcinomas of the genital and upper aero-digestive tract. Acta Obstet Gynecol Scand 1997;76:271-6. (Pubitemid 27122536)
9. Tsai ST, Li C, Jin YT, et al. High prevalence of human papillomavirus type 16 and 18 in middle-ear carcinomas. Int J cancer 1997;71:208-12. (Pubitemid 27252992)
10. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907. (Pubitemid 47371147)
11. Monk BJ, Tewari KS. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol 2007;107(2 Suppl 1):S6-13.
12. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
13. Kassim SK, Ibrahim SA, Eissa S, et al. Epstein-Barr virus, human papillomavirus, and flow cytometric cell cycle kinetics in nasopharyngeal carcinoma and inverted papilloma among Egyptian patients. Dis Markers 1998;14:113-20. (Pubitemid 28556448)
14. Krishna SM, James S, Kattoor J, et al. Human papilloma virus infection in Indian nasopharyngeal carcinomas in relation to the histology of tumour. Indian J Pathol Microbiol 2004;47:181-5. (Pubitemid 41656608)
15. Bryan RL, Bevan IS, Crocker J, et al. Detection of HPV 6 and 11 in tumours of the upper respiratory tract using the polymerase chain reaction. Clin Otolaryngol Allied Sci 1990;15:177-80. (Pubitemid 20277380)
16. Giannoudis A, Ergazaki M, Segas J, et al. Detection of Epstein-Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique. Cancer Lett 1995;89:177-81.
17. Shen J, Tate JE, Crum CP, et al. Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract. Mod Pathol 1996;9:15-20. (Pubitemid 26061950)
18. Rassekh CH, Rady PL, Arany I, et al. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope 1998;108:362-7. (Pubitemid 28136643)
19. Maxwell JH, Kumar B, Feng FY, et al. HPV-positive/p16-positive/ EBVnegative nasopharyngeal carcinoma in white North Americans. Head Neck 2010;32:562-7.
20. Tyan YS, Liu ST, Ong WR, et al. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors. J Clin Microbiol 1993;31:53-6.
21. Tung YC, Lin KH, Chu PY, et al. Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J Med Sci 1999;15:256-62.
22. Mirzamani N, Salehian P, Farhadi M, et al. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. Exp Mol Pathol 2006;81:231-4. (Pubitemid 44665861)
23. Hørding U, Nielsen HW, Daugaard S, et al. Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope 1994;104:99-102. (Pubitemid 24028044)
24. Punwaney R, Brandwein MS, Zhang DY, et al. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck 1999;21:21-9. (Pubitemid 29006452)
25. Lo EJ, Bell D, Woo JS, et al. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 2010;120:1990-7.
26. Chien CY, Su CY, Fang FM, et al. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol 2008;44:174-9.
27. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-9. (Pubitemid 351480538)
28. Kuo KT, Hsiao CH, Lin CH, et al. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol 2008;21:376-86.
29. Chung YL, Lee MY, Horng CF, et al. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head Neck 2009;31:9-20.
30. AJCC. Cancer Staging Manual. 6th edn. New York: Springer, 2002.
31. Hsu KF, Huang SC, Shiau AL, et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer 2007;17:174-81.
32. Huang HJ, Huang SL, Lin CY, et al. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 2004;14:639-49. (Pubitemid 39062921)
33. Plummer TB, Sperry AC, Xu HS, et al. In situ hybridization detection of low copy nucleic acid sequences using catalyzed reporter deposition and its usefulness in clinical human papillomavirus typing. Diagn Mol Pathol 1998;7:76-84.
34. Hsiao JR, Jin YT, Tsai ST. Detection of cell-free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer 2002;94:723-9.
35. Hsiao JR, Chang KC, Chen CW, et al. Endoplasmic reticulum stress triggers XBP-1-mediated upregulation of an EBV oncoprotein in nasopharyngeal carcinoma. Cancer Res 2009;69:4461-7.
36. Cooper K, Herrington CS, Stickland JE, et al. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol 1991;44:990-6.
37. Al Moustafa AE, Chen D, Ghabreau L, et al. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses 2009;73:184-6.
38. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;31:57-65.
39. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 1995;92:1654-8.
40. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995;69:2989-97.
41. Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91. (Pubitemid 34208640)
42. Huang LW, Seow KM. Oral sex is a risk factor for human papillomavirus-associated nasopharyngeal carcinoma in husbands of women with cervical cancer. Gynecol Obstet Invest 2010;70:73-5.
43. Gillison ML, Fakhry C. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006;24:2606-11. (Pubitemid 46622080)